A randomized phase ii study comparing four different interferon therapies in patients with recalcitrant condyloma acuminata.

被引:0
|
作者
Trizna, Z
Tyring, SK
机构
[1] UNIV TEXAS,MED BRANCH,DEPT DERMATOL,GALVESTON,TX 77550
[2] UNIV TEXAS,MED BRANCH,DEPT MICROBIOL & IMMUNOL,GALVESTON,TX 77550
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:206 / 206
页数:1
相关论文
共 50 条
  • [1] A randomized phase II study comparing four different interferon therapies in patients with recalcitrant condylomata acuminata
    Trizna, Z
    Evans, T
    Bruce, S
    Hatch, K
    Tyring, SK
    SEXUALLY TRANSMITTED DISEASES, 1998, 25 (07) : 361 - 365
  • [2] ETHAN: A phase II study comparing different endocrine therapies for male breast cancer.
    Leone, Jose Pablo
    Ruddy, Kathryn Jean
    Rashid, Naim
    Giordano, Sharon H.
    Gupta, Gaorav P.
    Hilsenbeck, Susan G.
    Gucalp, Ayca
    Walsh, Elaine M.
    Sukumar, Jasmine S.
    Makhlin, Igor
    Ortiz-Perez, Tamara
    Spanheimer, Philip Merle
    Calhoun, Benjamin C.
    Wolff, Antonio C.
    Krop, Ian E.
    Thompson, Alastair Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma
    Yamashita, Tatsuya
    Arai, Kuniaki
    Sunagozaka, Hajime
    Ueda, Teruyuki
    Terashima, Takeshi
    Yamashita, Taro
    Mizukoshi, Eishiro
    Sakai, Akito
    Nakamoto, Yasunari
    Honda, Masao
    Kaneko, Shuichi
    ONCOLOGY, 2011, 81 (5-6) : 281 - 290
  • [4] Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma
    Lee, CP
    Patel, PM
    Selby, PJ
    Hancock, BW
    Mak, I
    Pyle, L
    James, MG
    Beirne, DA
    Steeds, S
    A'Hern, R
    Gore, ME
    Eisen, T
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 898 - 903
  • [5] A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma.
    Pal, Sumanta K.
    Mortazavi, Amir
    Milowsky, Matthew I.
    Vaishampayan, Ulka N.
    Parikh, Mamta
    Lyou, Yung
    Wang, Peng
    Parikh, Rahul Atul
    Teply, Benjamin A.
    Dreicer, Robert
    Emamekhoo, Hamid
    Michaelson, M. Dror
    Hoimes, Christopher J.
    Zhang, Tian
    Srinivas, Sandy
    Kim, William Y.
    Liu, Glenn
    Frankel, Paul Henry
    Cui, Yuijie
    Lara, Primo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
    Pecherstorfer, M
    Herrmann, Z
    Body, JJ
    Manegold, C
    Degardin, M
    Clemens, MR
    Thurlimann, B
    TubianaHulin, M
    Steinhauer, EU
    vanEijkeren, M
    Huss, HJ
    Thiebaud, D
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 268 - 276
  • [7] How should transection of the liver be performed? A prospective randomized study in 100 consecutive patients: Comparing four different transection strategies
    Lesurtel, M
    Selzner, M
    Petrowsky, H
    McCormack, L
    Clavien, PA
    ANNALS OF SURGERY, 2005, 242 (06) : 814 - 823
  • [8] A RANDOMIZED PHASE-I PHASE II STUDY OF CONTINUOUS VERSUS INTERMITTENT INTRAVENOUS INTERFERON-GAMMA IN PATIENTS WITH METASTATIC MELANOMA
    ERNSTOFF, MS
    TRAUTMAN, T
    DAVIS, CA
    REICH, SD
    WITMAN, P
    BALSER, J
    RUDNICK, S
    KIRKWOOD, JM
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (11) : 1804 - 1810
  • [9] A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II
    Harvey, V. J.
    Sharples, K. J.
    Isaacs, R. J.
    Jameson, M. B.
    Jeffery, G. M.
    McLaren, B. R.
    Pollard, S.
    Riley, G. A.
    Simpson, A. B.
    Hinder, V. A.
    Scott, J. N.
    Dzhelali, M. V.
    Findlay, M. P.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1828 - 1834
  • [10] A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
    Middleton M.R.
    Lorigan P.
    Owen J.
    Ashcroft L.
    Lee S.M.
    Harper P.
    Thatcher N.
    British Journal of Cancer, 2000, 82 (6) : 1158 - 1162